Behavior of total complement as a humoral parameter of nonspecific resistance in hormonal contraception and pregnancy

Dtsch Gesundheitsw. 1976 Dec 1;31(49):2305-8.

Abstract

PIP: Total complement levels were studied in 216 pregnant women, 170 women (aged 18-46 years) taking Non-Ovlon or Ovosiston, and 305 male and female blood donors. Complement titers in the pregnant group were significantly higher than those of controls; those of women using hormonal contraception were similar to those of the pregnant group. The question of steroid induction of immunological phenomena is discussed.

MeSH terms

  • Adult
  • Blood Donors
  • Chlormadinone Acetate / pharmacology
  • Complement System Proteins* / analysis
  • Contraceptives, Oral, Hormonal / pharmacology
  • Ethinyl Estradiol / pharmacology
  • Female
  • Humans
  • Immunity / drug effects*
  • Male
  • Mestranol / pharmacology
  • Norethindrone / pharmacology
  • Pregnancy

Substances

  • Contraceptives, Oral, Hormonal
  • Chlormadinone Acetate
  • Ethinyl Estradiol
  • Complement System Proteins
  • Mestranol
  • Norethindrone